{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:26:00Z","timestamp":1789979160081,"version":"4.0.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC101-2314-B010-024-MY3"],"award-info":[{"award-number":["NSC101-2314-B010-024-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V101C-188"],"award-info":[{"award-number":["V101C-188"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V102C-060"],"award-info":[{"award-number":["V102C-060"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V102C-129"],"award-info":[{"award-number":["V102C-129"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V103C-043"],"award-info":[{"award-number":["V103C-043"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V104C-026"],"award-info":[{"award-number":["V104C-026"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V104C-050"],"award-info":[{"award-number":["V104C-050"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V105C-075"],"award-info":[{"award-number":["V105C-075"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V106C-036"],"award-info":[{"award-number":["V106C-036"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V102E2-001"],"award-info":[{"award-number":["V102E2-001"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-2314-B-010 -032 -MY3"],"award-info":[{"award-number":["MOST 104-2314-B-010 -032 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189126","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T13:29:36Z","timestamp":1512653376000},"page":"e0189126","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2338-3561","authenticated-orcid":true,"given":"Chih-Ching","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Te","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Chang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Juei","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Sin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo-Ming","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Cherng","family":"Tarng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"BM Brenner","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"EJ Lewis","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2006121372","article-title":"Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency","volume":"18","author":"FF Hou","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jamainternmed.2013.12700","article-title":"Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia","volume":"174","author":"TW Hsu","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-148-1-200801010-00190","article-title":"Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease","volume":"148","author":"R Kunz","year":"2008","journal-title":"Ann Intern Med"},{"issue":"9638","key":"ref6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"372","author":"JF Mann","year":"2008","journal-title":"Lancet"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-156-8-201204170-00008","article-title":"Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline","volume":"156","author":"HA Fink","year":"2012","journal-title":"Ann Intern Med"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists","volume":"57","author":"MW Taal","year":"2000","journal-title":"Kidney Int"},{"issue":"20","key":"ref9","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"LF Fried","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3349\/ymj.2003.44.3.463","article-title":"Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy","volume":"44","author":"MJ Kim","year":"2003","journal-title":"Yonsei Med J"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5414\/CNP60318","article-title":"The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy","volume":"60","author":"JH Song","year":"2003","journal-title":"Clin Nephrol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jdi.12050","article-title":"Microinflammation in the pathogenesis of diabetic nephropathy","volume":"4","author":"K Shikata","year":"2013","journal-title":"J Diabetes Investig"},{"issue":"23","key":"ref13","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"HH Parving","year":"2012","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2369-13-89","article-title":"Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease","volume":"13","author":"SY Li","year":"2012","journal-title":"BMC Nephrol"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ki.2011.228","article-title":"Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients","volume":"80","author":"KE Chan","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1681\/ASN.2011030287","article-title":"Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis","volume":"23","author":"JL Gamboa","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12882-015-0162-x","article-title":"Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis\u2014a randomized cross-over study","volume":"16","author":"JL Gamboa","year":"2015","journal-title":"BMC Nephrol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004872-200018010-00013","article-title":"Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease","volume":"18","author":"LM Ruilope","year":"2000","journal-title":"J Hypertens"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"LM Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1186\/cc11872","article-title":"Severe hyperkalemia requiring hospitalization: predictors of mortality","volume":"16","author":"JN An","year":"2012","journal-title":"Crit Care"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0891-6632(90)90057-C","article-title":"Hyperkalemia in diabetes mellitus","volume":"4","author":"J Uribarri","year":"1990","journal-title":"J Diabet Complications"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/aje\/kwi307","article-title":"Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods","volume":"162","author":"Z Zhou","year":"2005","journal-title":"Am J Epidemiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T13:34:19Z","timestamp":1589808859000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189126"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189126","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732240576.793540922","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.732240576.793542016","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]}}}